Enzymatic- and temperature-sensitive controlled release of ultrasmall superparamagnetic iron oxides (USPIOs)

Journal of Nanobiotechnology

Volumn 9, Issue , 2011, Pages

  Yu, Shann S ^a   Scherer, Randy L ^a   Ortega, Ryan A ^a   Bell, Charleson S ^a   O'Neil, Conlin P ^b   Hubbell, Jeffrey A ^b   Giorgio, Todd D ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIPHILICS; ANIONIC RING OPENING POLYMERIZATION; ATHEROSCLEROTIC PLAQUE; BIOSENSING APPLICATIONS; CLEAVAGE SITES; CONTRAST AGENT; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE; DELIVERY SYSTEMS; ENZYMATIC ACTIVITIES; FUNCTIONALIZATIONS; HYDRATION METHOD; MODULAR DESIGNS; MONODISPERSE; OXIDATIVE ENVIRONMENT; POLYMER PLATFORM; POTENTIAL APPLICATIONS; PROOF OF CONCEPT; PROTEOLYTIC ACTIVITIES; RE-CLUSTERING; TEMPERATURE SENSITIVITY; TEMPERATURE-SENSITIVE; THERMO-RESPONSIVE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIONIC POLYMERIZATION; CHEMICAL REACTIONS; COPOLYMERIZATION; COPOLYMERS; DESIGN; DISEASES; ETHYLENE; ETHYLENE GLYCOL; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MICELLES; NANOMAGNETICS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYMERS; PROPYLENE; RESONANCE; RING OPENING POLYMERIZATION; SUPERPARAMAGNETISM;

CONTROLLED DRUG DELIVERY;

COPOLYMER; MACROGOL; POLYMER; PROPYLENE; PROPYLENE SULFIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; CROSS LINKING REAGENT; DEXTRAN; FERUMOXTRAN-10; MACROGOL DERIVATIVE; MAGNETITE NANOPARTICLE; POLY(ETHYLENE GLYCOL) STABILIZED POLY(PROPYLENE SULFIDE); POLY(ETHYLENE GLYCOL)-STABILIZED POLY(PROPYLENE SULFIDE); SULFIDE;

ARTICLE; BIOSENSOR; CONTROLLED RELEASE FORMULATION; CROSS LINKING; DRUG DELIVERY SYSTEM; ENCAPSULATION; ENZYME ACTIVITY; ENZYME KINETICS; POLYMERIZATION; RING OPENING; SYNTHESIS; TEMPERATURE SENSITIVITY; ERRATUM; ERROR; CHEMISTRY; DELAYED RELEASE FORMULATION; MICELLE;

CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DEXTRANS; MAGNETITE NANOPARTICLES; MICELLES; POLYETHYLENE GLYCOLS; SULFIDES;

EID: 79951959293     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-9-7     Document Type: Article

References (46)

1. Scherer RL, McIntyre JO, Matrisian LM. Imaging matrix metalloproteinases in cancer. Cancer Metastasis Rev 2008, 27:679-690. 10.1007/s10555-008-9152-9, 18465089.
2. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002, 90:251-262.
3. Thornton PD, Heise A. Highly specific dual enzyme-mediated payload release from peptide-coated silica particles. J Am Chem Soc 2010, 132:2024-2028. 10.1021/ja9094439, 20099895.
4. Venkatesh S, Wower J, Byrne ME. Nucleic acid therapeutic carriers with on-demand triggered release. Bioconjug Chem 2009, 20:1773-1782. 10.1021/bc900187b, 19670897.
5. Schlossbauer A, Kecht J, Bein T. Biotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica. Angew Chem Int Ed Engl 2009, 48:3092-3095. 10.1002/anie.200805818, 19309022.
6. Chang E, Miller JS, Sun J, Yu WW, Colvin VL, Drezek R, West JL. Protease-activated quantum dot probes. Biochem Biophys Res Commun 2005, 334:1317-1321. 10.1016/j.bbrc.2005.07.028, 16039606.
7. McIntyre JO, Fingleton B, Wells KS, Piston DW, Lynch CC, Gautam S, Matrisian LM. Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. Biochem J 2004, 377:617-628. 10.1042/BJ20030582, 1223892, 14556651.
8. Jeong U, Teng XW, Wang Y, Yang H, Xia YN. Superparamagnetic colloids: Controlled synthesis and niche applications. Advanced Materials 2007, 19:33-60.
9. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 1999, 10:186-191. 10.1021/bc980125h, 10077466.
10. Park JH, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl 2008, 47:7284-7288. 10.1002/anie.200801810, 18696519.
11. Perez JM, Josephson L, Weissleder R. Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. Chembiochem 2004, 5:261-264. 10.1002/cbic.200300730, 14997516.
12. Cormode DP, Skajaa T, Fayad ZA, Mulder WJ. Nanotechnology in medical imaging: probe design and applications. Arteriosclerosis, thrombosis, and vascular biology 2009, 29:992-1000. 10.1161/ATVBAHA.108.165506, 2844987, 19057023.
13. Cormode DP, Briley-Saebo KC, Mulder WJ, Aguinaldo JG, Barazza A, Ma Y, Fisher EA, Fayad ZA. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. Small 2008, 4:1437-1444. 10.1002/smll.200701285, 18712752.
14. Woo K, Hong J, Choi S, Lee HW, Ahn JP, Kim CS, Lee SW. Easy synthesis and magnetic properties of iron oxide nanoparticles. Chemistry of Materials 2004, 16:2814-2818.
15. Xie J, Peng S, Brower N, Pourmand N, Wang SX, Sun SH. One-pot synthesis of monodisperse iron oxide nanoparticles for potential biomedical applications. Pure and Applied Chemistry 2006, 78:1003-1014.
16. Kohler N, Fryxell GE, Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc 2004, 126:7206-7211. 10.1021/ja049195r, 15186157.
17. Talelli M, Rijcken CJ, Lammers T, Seevinck PR, Storm G, van Nostrum CF, Hennink WE. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Langmuir 2009, 25:2060-2067. 10.1021/la8036499, 19166276.
18. Nitin N, LaConte LE, Zurkiya O, Hu X, Bao G. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J Biol Inorg Chem 2004, 9:706-712. 10.1007/s00775-004-0560-1, 15232722.
19. Hermanson GT. Bioconjugate Techniques. 2008, San Diego: Academic Press, 2.
20. Briley-Saebo KC, Mani V, Hyafil F, Cornily JC, Fayad ZA. Fractionated Feridex and positive contrast: in vivo MR imaging of atherosclerosis. Magn Reson Med 2008, 59:721-730. 10.1002/mrm.21541, 18383304.
21. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 2004, 39:56-63. 10.1097/01.rli.0000101027.57021.28, 14701989.
22. Bonnemain B. Superparamagnetic Agents in Magnetic Resonance Imaging: Physicochemical Characteristics and Clinical Applications A Review. Journal of Drug Targeting 1998, 6:167-174. 10.3109/10611869808997890, 9888302.
23. Tan YF, Chandrasekharan P, Maity D, Yong CX, Chuang KH, Zhao Y, Wang S, Ding J, Feng SS. Multimodal tumor imaging by iron oxides and quantum dots formulated in poly (lactic acid)-d-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles. Biomaterials 2011,
24. Foy SP, Manthe RL, Foy ST, Dimitrijevic S, Krishnamurthy N, Labhasetwar V. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. ACS Nano 2010, 4:5217-5224. 10.1021/nn101427t, 20731413.
25. Pouliquen D, Lucet I, Chouly C, Perdrisot R, Le Jeune JJ, Jallet P. Liver-directed superparamagnetic iron oxide: quantitation of T2 relaxation effects. Magn Reson Imaging 1993, 11:219-228. 10.1016/0730-725X(93)90026-A, 8455432.
26. Pochon S, Hyacinthe R, Terrettaz J, Robert F, Schneider M, Tournier H. Long circulating superparamagnetic particles with high T2 relaxivity. Acta Radiol Suppl 1997, 412:69-72.
27. Kim BS, Qiu JM, Wang JP, Taton TA. Magnetomicelles: composite nanostructures from magnetic nanoparticles and cross-linked amphiphilic block copolymers. Nano Lett 2005, 5:1987-1991. 10.1021/nl0513939, 16218723.
28. Ai H, Flask C, Weinberg B, Shuai X, Pagel MD, Farrell D, Duerk J, Gao JM. Magnetite-loaded polymeric micelles as ultrasensitive magnetic-resonance probes. Advanced Materials 2005, 17:1949-+.
29. Napoli A, Tirelli N, Wehrli E, Hubbell JA. Lyotropic behavior in water of amphiphilic ABA triblock copolymers based on poly(propylene sulfide) and poly(ethylene glycol). Langmuir 2002, 18:8324-8329.
30. Napoli A, Valentini M, Tirelli N, Muller M, Hubbell JA. Oxidation-responsive polymeric vesicles. Nat Mater 2004, 3:183-189. 10.1038/nmat1081, 14991021.
31. Rehor A, Hubbell JA, Tirelli N. Oxidation-sensitive polymeric nanoparticles. Langmuir 2005, 21:411-417. 10.1021/la0478043, 15620332.
32. Segura T, Hubbell JA. Synthesis and in vitro characterization of an ABC triblock copolymer for siRNA delivery. Bioconjug Chem 2007, 18:736-745. 10.1021/bc060284y, 17358044.
33. Perez JM, Josephson L, O'Loughlin T, Hogemann D, Weissleder R. Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol 2002, 20:816-820.
34. Cerritelli S, Velluto D, Hubbell JA. PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. Biomacromolecules 2007, 8:1966-1972. 10.1021/bm070085x, 17497921.
35. Napoli A, Tirelli N, Kilcher G, Hubbell JA. New synthetic methodologies for amphiphilic multiblock copolymers of ethylene glycol and propylene sulfide. Macromolecules 2001, 34:8913-8917.
36. O'Neil CP, Suzuki T, Demurtas D, Finka A, Hubbell JA. A novel method for the encapsulation of biomolecules into polymersomes via direct hydration. Langmuir 2009, 25:9025-9029.
37. O'Neil CP, van der Vlies AJ, Velluto D, Wandrey C, Demurtas D, Dubochet J, Hubbell JA. Extracellular matrix binding mixed micelles for drug delivery applications. J Control Release 2009, 137:146-151.
38. Rehor A, Tirelli N, Hubbell JA. A new living emulsion polymerization mechanism: Episulfide anionic polymerization. Macromolecules 2002, 35:8688-8693.
39. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298:1759-1762. 10.1126/science.1077194, 12459582.
40. Yu WW, Chang E, Falkner JC, Zhang J, Al-Somali AM, Sayes CM, Johns J, Drezek R, Colvin VL. Forming biocompatible and nonaggregated nanocrystals in water using amphiphilic polymers. J Am Chem Soc 2007, 129:2871-2879. 10.1021/ja067184n, 17309256.
41. Yu WW, Chang E, Sayes CM, Drezek R, Colvin VL. Aqueous dispersion of monodisperse magnetic iron oxide nanocrystals through phase transfer. Nanotechnology 2006, 17:4483-4487.
42. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008, 108:2064-2110. 10.1021/cr068445e, 18543879.
43. Zhang L, He R, Gu HC. Oleic acid coating on the monodisperse magnetite nanoparticles. Applied Surface Science 2006, 253:2611-2617.
44. Christian GD. Analytical chemistry. 1994, New York: Wiley & Sons, 5.
45. Lee JH, Huh YM, Jun YW, Seo JW, Jang JT, Song HT, Kim S, Cho EJ, Yoon HG, Suh JS, Cheon J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13:95-99. 10.1038/nm1467, 17187073.
46. LaConte LEW, Nitin N, Zurkiya O, Caruntu D, O'Connor CJ, Hu XP, Bao G. Coating thickness of magnetic iron oxide nanoparticles affects R-2 relaxivity. Journal of Magnetic Resonance Imaging 2007, 26:1634-1641. 10.1002/jmri.21194, 17968941.